{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:15:20Z","timestamp":1793423720803,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T00:00:00Z","timestamp":1604966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T00:00:00Z","timestamp":1604966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s13555-020-00460-1","type":"journal-article","created":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T15:42:45Z","timestamp":1605022965000},"page":"1-12","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":87,"title":["Rosacea and the Microbiome: A Systematic Review"],"prefix":"10.1007","volume":"11","author":[{"given":"Hala","family":"Daou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Paradiso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry","family":"Hennessy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Seminario-Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,10]]},"reference":[{"issue":"1","key":"460_CR1","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jaad.2017.07.055","volume":"78","author":"AD Holmes","year":"2018","unstructured":"Holmes AD, Spoendlin J, Chien AL, Baldwin H, Chang ALS. Evidence-based update on rosacea comorbidities and their common physiologic pathways. J Am Acad Dermatol. 2018;78(1):156\u201366.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"460_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.5826\/dpc.0704a08","volume":"7","author":"E Weiss","year":"2017","unstructured":"Weiss E, Katta R. Diet and rosacea: the role of dietary change in the management of rosacea. Dermatol Pract Concept. 2017;7(4):31\u20137.","journal-title":"Dermatol Pract Concept"},{"issue":"34","key":"460_CR3","doi-asserted-by":"publisher","first-page":"11950","DOI":"10.3748\/wjg.v20.i34.11950","volume":"20","author":"F Wong","year":"2014","unstructured":"Wong F, Rayner-Hartley E, Byrne MF. Extraintestinal manifestations of Helicobacter pylori: a concise review. World J Gastroenterol. 2014;20(34):11950\u201361.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"460_CR4","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.jaad.2013.08.006","volume":"69","author":"AD Holmes","year":"2013","unstructured":"Holmes AD. Potential role of microorganisms in the pathogenesis of rosacea. J Am Acad Dermatol. 2013;69(6):1025\u201332.","journal-title":"J Am Acad Dermatol"},{"issue":"1\u20132","key":"460_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3121\/cmr.2017.1379a","volume":"16","author":"V Rastogi","year":"2018","unstructured":"Rastogi V, Singh D, Mazza JJ, Parajuli D, Yale SH. Flushing disorders associated with gastrointestinal symptoms: part 1, neuroendocrine tumors, mast cell disorders and hyperbasophila. Clin Med Res. 2018;16(1\u20132):16\u201328.","journal-title":"Clin Med Res"},{"key":"460_CR6","doi-asserted-by":"publisher","first-page":"S449","DOI":"10.14309\/00000434-201110002-01195","volume":"106","author":"L Weinstock","year":"2011","unstructured":"Weinstock L. Crohn\u2019s disease and rosacea: effect of rifaximin and adalimumab. Am J Gastroenterol. 2011;106:S449.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"460_CR7","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.jaad.2014.08.028","volume":"72","author":"AM Two","year":"2015","unstructured":"Two AM, Wu W, Gallo RL, Hata TR. Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors. J Am Acad Dermatol. 2015;72(5):749\u201358 (quiz 759\u2013760).","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"460_CR8","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1111\/j.1365-2133.2012.11114.x","volume":"167","author":"N O'Reilly","year":"2012","unstructured":"O\u2019Reilly N, Menezes N, Kavanagh K. Positive correlation between serum immunoreactivity to Demodex-associated Bacillus proteins and erythematotelangiectatic rosacea. Br J Dermatol. 2012;167(5):1032\u20136.","journal-title":"Br J Dermatol"},{"issue":"3","key":"460_CR9","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1365-2230.2004.01461.x","volume":"29","author":"SN Kendall","year":"2004","unstructured":"Kendall SN. Remission of rosacea induced by reduction of gut transit time. Clin Exp Dermatol. 2004;29(3):297\u20139.","journal-title":"Clin Exp Dermatol"},{"key":"460_CR10","doi-asserted-by":"publisher","unstructured":"Wang R, Farhat M, Na J, Li R, Wu Y. Bacterial and fungal microbiome characterization in patients with rosacea and healthy controls. Br J Dermatol. 2020. https:\/\/doi.org\/10.1111\/bjd.19315.","DOI":"10.1111\/bjd.19315"},{"issue":"1","key":"460_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jaad.2016.08.022","volume":"76","author":"M Kim","year":"2017","unstructured":"Kim M, Choi KH, Hwang SW, Lee YB, Park HJ, Bae JM. Inflammatory bowel disease is associated with an increased risk of inflammatory skin diseases: a population-based cross-sectional study. J Am Acad Dermatol. 2017;76(1):40\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"460_CR12","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1111\/exd.12030","volume":"21","author":"C Casas","year":"2012","unstructured":"Casas C, Paul C, Lahfa M, et al. Quantification of Demodex folliculorum by PCR in rosacea and its relationship to skin innate immune activation. Exp Dermatol. 2012;21(12):906\u201310.","journal-title":"Exp Dermatol"},{"key":"460_CR13","doi-asserted-by":"publisher","unstructured":"Searle T, Ali FR, Carolides S, Al-Niaimi F. Rosacea and the gastrointestinal system. Australas J Dermatol. 2020. https:\/\/doi.org\/10.1111\/ajd.13401.","DOI":"10.1111\/ajd.13401"},{"issue":"4","key":"460_CR14","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/j.1365-2133.2011.10746.x","volume":"166","author":"N O'Reilly","year":"2012","unstructured":"O\u2019Reilly N, Bergin D, Reeves EP, McElvaney NG, Kavanagh K. Demodex-associated bacterial proteins induce neutrophil activation. Br J Dermatol. 2012;166(4):753\u201360.","journal-title":"Br J Dermatol"},{"issue":"1","key":"460_CR15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jaad.2009.12.036","volume":"64","author":"M Whitfeld","year":"2011","unstructured":"Whitfeld M, Gunasingam N, Leow LJ, Shirato K, Preda V. Staphylococcus epidermidis: a possible role in the pustules of rosacea. J Am Acad Dermatol. 2011;64(1):49\u201352.","journal-title":"J Am Acad Dermatol"},{"key":"460_CR16","doi-asserted-by":"crossref","unstructured":"Rainer BM, Fischer AH, Luz Felipe da Silva D, Kang S, Chien AL. Rosacea is associated with chronic systemic diseases in a skin severity-dependent manner: results of a case-control study. J Am Acad Dermatol. 2015;73(4):604\u20138.","DOI":"10.1016\/j.jaad.2015.07.009"},{"issue":"1","key":"460_CR17","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/bjd.14930","volume":"176","author":"A Egeberg","year":"2017","unstructured":"Egeberg A, Weinstock LB, Thyssen EP, Gislason GH, Thyssen JP. Rosacea and gastrointestinal disorders: a population-based cohort study. Br J Dermatol. 2017;176(1):100\u20136.","journal-title":"Br J Dermatol"},{"issue":"1","key":"460_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/exd.13398","volume":"27","author":"JH Nam","year":"2018","unstructured":"Nam JH, Yun Y, Kim HS, et al. Rosacea and its association with enteral microbiota in Korean females. Exp Dermatol. 2018;27(1):37\u201342.","journal-title":"Exp Dermatol"},{"issue":"4","key":"460_CR19","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2165\/00128071-200203040-00005","volume":"3","author":"B Wedi","year":"2002","unstructured":"Wedi B, Kapp A. Helicobacter pylori infection in skin diseases: a critical appraisal. Am J Clin Dermatol. 2002;3(4):273\u201382.","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"460_CR20","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/S0190-9622(99)70493-7","volume":"40","author":"S Utas","year":"1999","unstructured":"Utas S, Ozbakir O, Turasan A, Utas C. Helicobacter pylori eradication treatment reduces the severity of rosacea. J Am Acad Dermatol. 1999;40(3):433\u20135.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"460_CR21","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1001\/archderm.135.6.659","volume":"135","author":"JT Bamford","year":"1999","unstructured":"Bamford JT, Tilden RL, Blankush JL, Gangeness DE. Effect of treatment of Helicobacter pylori infection on rosacea. Arch Dermatol. 1999;135(6):659\u201363.","journal-title":"Arch Dermatol"},{"issue":"5","key":"460_CR22","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3346\/jkms.2000.15.5.551","volume":"15","author":"H Herr","year":"2000","unstructured":"Herr H, You CH. Relationship between Helicobacter pylori and rosacea: it may be a myth. J Korean Med Sci. 2000;15(5):551\u20134.","journal-title":"J Korean Med Sci"},{"issue":"42","key":"460_CR23","doi-asserted-by":"publisher","first-page":"15657","DOI":"10.3748\/wjg.v20.i42.15657","volume":"20","author":"WX Chen","year":"2014","unstructured":"Chen WX, Ren LH, Shi RH. Enteric microbiota leads to new therapeutic strategies for ulcerative colitis. World J Gastroenterol. 2014;20(42):15657\u201363.","journal-title":"World J Gastroenterol"},{"issue":"11","key":"460_CR24","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1111\/exd.14016","volume":"28","author":"M Sz\u00e1nt\u00f3","year":"2019","unstructured":"Sz\u00e1nt\u00f3 M, D\u00f3zsa A, Antal D, Szab\u00f3 K, Kem\u00e9ny L, Bai P. Targeting the gut-skin axis\u2014probiotics as new tools for skin disorder management? Exp Dermatol. 2019;28(11):1210\u20138.","journal-title":"Exp Dermatol"},{"issue":"2","key":"460_CR25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.det.2017.11.006","volume":"36","author":"N Vera","year":"2018","unstructured":"Vera N, Patel NU, Seminario-Vidal L. Rosacea comorbidities. Dermatol Clin. 2018;36(2):115\u201322.","journal-title":"Dermatol Clin"},{"issue":"3","key":"460_CR26","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1097\/MIB.0000000000000644","volume":"22","author":"J Spoendlin","year":"2016","unstructured":"Spoendlin J, Karatas G, Furlano RI, Jick SS, Meier CR. Rosacea in patients with ulcerative colitis and Crohn\u2019s disease: a population-based case-control study. Inflamm Bowel Dis. 2016;22(3):680\u20137.","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"460_CR27","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.jaad.2017.09.016","volume":"78","author":"R Haber","year":"2018","unstructured":"Haber R, El Gemayel M. Comorbidities in rosacea: a systematic review and update. J Am Acad Dermatol. 2018;78(4):786-792.e788.","journal-title":"J Am Acad Dermatol"},{"key":"460_CR28","doi-asserted-by":"crossref","unstructured":"Li WQ, Cho E, Khalili H, Wu S, Chan AT, Qureshi AA. Rosacea, use of tetracycline, and risk of incident inflammatory bowel disease in women. Clin Gastroenterol Hepatol. 2016;14(2):220\u2013225.e221\u20133.","DOI":"10.1016\/j.cgh.2015.09.013"},{"issue":"5","key":"460_CR29","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.jaad.2016.11.065","volume":"76","author":"CY Wu","year":"2017","unstructured":"Wu CY, Chang YT, Juan CK, et al. Risk of inflammatory bowel disease in patients with rosacea: results from a nationwide cohort study in Taiwan. J Am Acad Dermatol. 2017;76(5):911\u20137.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"460_CR30","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/ng.3176","volume":"47","author":"P Goyette","year":"2015","unstructured":"Goyette P, Boucher G, Mallon D, et al. High-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis. Nat Genet. 2015;47(2):172\u20139.","journal-title":"Nat Genet"},{"issue":"6","key":"460_CR31","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1038\/jid.2015.53","volume":"135","author":"ALS Chang","year":"2015","unstructured":"Chang ALS, Raber I, Xu J, et al. Assessment of the genetic basis of rosacea by genome-wide association study. J Invest Dermatol. 2015;135(6):1548\u201355.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"460_CR32","doi-asserted-by":"publisher","first-page":"126","DOI":"10.5021\/ad.2012.24.2.126","volume":"24","author":"M Reinholz","year":"2012","unstructured":"Reinholz M, Ruzicka T, Schauber J. Cathelicidin LL-37: an antimicrobial peptide with a role in inflammatory skin disease. Ann Dermatol. 2012;24(2):126\u201335.","journal-title":"Ann Dermatol"},{"issue":"7","key":"460_CR33","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.cgh.2008.02.054","volume":"6","author":"A Parodi","year":"2008","unstructured":"Parodi A, Paolino S, Greco A, et al. Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication. Clin Gastroenterol Hepatol. 2008;6(7):759\u201364.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"18","key":"460_CR34","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1056\/NEJMcp1506630","volume":"377","author":"EJ van Zuuren","year":"2017","unstructured":"van Zuuren EJ. Rosacea. N Engl J Med. 2017;377(18):1754\u201364.","journal-title":"N Engl J Med"},{"issue":"4","key":"460_CR35","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.jaad.2020.04.129","volume":"83","author":"JGM Logger","year":"2020","unstructured":"Logger JGM, Olydam JI, Driessen RJB. Use of beta-blockers for rosacea-associated facial erythema and flushing: a systematic review and update on proposed mode of action. J Am Acad Dermatol. 2020;83(4):1088\u201397.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"460_CR36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jdermsci.2015.12.006","volume":"82","author":"A Margalit","year":"2016","unstructured":"Margalit A, Kowalczyk MJ, \u017baba R, Kavanagh K. The role of altered cutaneous immune responses in the induction and persistence of rosacea. J Dermatol Sci. 2016;82(1):3\u20138.","journal-title":"J Dermatol Sci"},{"issue":"1","key":"460_CR37","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/1346-8138.12687","volume":"42","author":"JM Park","year":"2015","unstructured":"Park JM, Mun JH, Song M, et al. Propranolol, doxycycline and combination therapy for the treatment of rosacea. J Dermatol. 2015;42(1):64\u20139.","journal-title":"J Dermatol"},{"issue":"23","key":"460_CR38","doi-asserted-by":"publisher","first-page":"5415","DOI":"10.3748\/wjg.v22.i23.5415","volume":"22","author":"E Manzhalii","year":"2016","unstructured":"Manzhalii E, Hornuss D, Stremmel W. Intestinal-borne dermatoses significantly improved by oral application of Escherichia coli Nissle 1917. World J Gastroenterol. 2016;22(23):5415\u201321.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"460_CR39","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/dth.12355","volume":"29","author":"MC Fortuna","year":"2016","unstructured":"Fortuna MC, Garelli V, Pranteda G, et al. A case of scalp rosacea treated with low dose doxycycline and probiotic therapy and literature review on therapeutic options. Dermatol Ther. 2016;29(4):249\u201351.","journal-title":"Dermatol Ther"},{"key":"460_CR40","doi-asserted-by":"crossref","unstructured":"Pelle MT, Crawford GH, James WD. Rosacea: II. Therapy. J Am Acad Dermatol. 2004;51(4):499\u201312 (quiz 513\u2013494).","DOI":"10.1016\/j.jaad.2004.03.033"},{"key":"460_CR41","unstructured":"Efficacy and tolerability of erenumab in the management of persistent redness and flushing in rosacea. https:\/\/ClinicalTrials.gov\/show\/NCT04419259. Accessed 12 Sept 2020."},{"key":"460_CR42","unstructured":"Timolol for the treatment of acne and rosacea. https:\/\/ClinicalTrials.gov\/show\/NCT02774590. Accessed 12 Sept 2020."},{"key":"460_CR43","unstructured":"Safety and efficacy of rifaximin in patients with papulopustular rosacea and positive lactulose breath test. https:\/\/ClinicalTrials.gov\/show\/NCT03864978. Accessed 12 Sept 2020."},{"key":"460_CR44","unstructured":"Pulsed dye laser treatment and oxymetazoline hydrochloride (HCl) 1% cream for erythematotelangiectatic rosacea. https:\/\/ClinicalTrials.gov\/show\/NCT04153188. Accessed 12 Sept 2020."}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-020-00460-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13555-020-00460-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-020-00460-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T18:06:20Z","timestamp":1612375580000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13555-020-00460-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,10]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["460"],"URL":"https:\/\/doi.org\/10.1007\/s13555-020-00460-1","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,10]]},"assertion":[{"value":"23 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}